The Guerriero Lab aims to design clinically effective strategies to promote T-cell activation and weaken the immune-suppressive tumor microenvironment to improve immunotherapy response rates in breast cancer patients. We seek to identify tumor-promoting tumor macrophages in breast tumors before and after therapy, elucidate their molecular and metabolic regulation that promotes immune suppression and therapy-resistance and determine how tumor macrophage phenotype, metabolism and function can be modulated for anti-tumor responses.
Guerriero Lab at SITC 2024
From November 5th-10th the Guerriero lab attended the 39th SITC annual meeting in Houston. It was a week full of great presentations and conversations with colleagues. We hope to see…
Guerriero Lab 4th Anniversary
On October 4th, we celebrated the 4th anniversary of the Guerriero Lab. The past 4 years have been filled with great science, collaborations, and people. Can't wait to see what…
CIMT Annual Meeting
It was a privilege to present our research at the Association for Cancer Immunotherapy (CIMT) conference this year in Mainz Germany. It was a fantastic three days of great talks…